SLC25A15P2

Across TCGA pan-cancer cohorts, SLC25A15P2 RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated SLC25A15P2 data layer.

The strongest signal is observed in rectum adenocarcinoma (READ), where higher SLC25A15P2 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated SLC25A15P2 expression acts as an unfavorable survival marker, although some lineages such as BRCA and GBM show a favorable association.

READ, UCEC, and UVM are the cancer types where SLC25A15P2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
READ	DFS	Tertile	All	0.189	0.567	<.001	96	view →
UCEC	OS	Tertile	All	0.292	0.729	<.001	90	view →
UVM	DFS	Tertile	All	0.518	0.834	<.001	87	view →
KIRP	DFS	Tertile	II,III,IV	0.114	0.746	<.001	73	view →
THYM	OS	Quartile	All	0.842	1.000	.005	32	view →
BRCA	DFS	Tertile	All	0.606	0.500	.020	30	view →
PAAD	OS	Tertile	All	0.234	0.501	.004	27	view →
KICH	OS	Tertile	II,III,IV	0.197	0.877	.021	27	view →
GBM	OS	Tertile	All	0.395	0.226	.010	18	view →
ACC	OS	Tertile	III,IV	0.145	0.484	.011	18	view →
KIRC	DFS	Tertile	IV	0.362	0.657	.015	12	view →
SKCM	DFS	Tertile	IV	0.051	0.476	.023	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 19 lineages.

SLC25A15P2–READ (DFS)

Open the READ breakdown →